IL6 and hydrops fetalis: The first concept was shaped in the 1990s when early studies revealed that patients with HF exhibited elevated circulating levels of proinflammatory cytokines such as tumor necrosis factor (TNF), interleukin-1β (IL-1β), and interleukin-6 (IL-6), compared with healthy individuals [105,106,107].